hyperglycemia such as diabetes mellitus. The accumulated intracellular sorbitol causes development of diabetic complications such as cataracts, neuropathy, retinopathy and nephropathy1). Inhibitors of aldose reductase have been shown to reverse these biochemical changes and have been proven effective in delaying and even preventing several diabetic pathologies. Thus, aldose reductase has become an attractive pharmacological target for the treatment of diabetic complications. It has been reported that inhibitors of aldose reductase reduce the tissue sorbitol content in diabetic animals and are useful as therapeutic agents for diabetic complications2).
In our screening programme on bioactive molecules through the fermentation route3-7), we screened 15 different strains of Aspergillus sp. for potential inhibitors against rat lens aldose reductase (RLAR). We found that, Aspergillus niger CFR-1046 produced a compound, termed by us as asperaldin, which exhibits potent inhibitory activity against RLAR. The present paper describes the fermentation, Table 1 . The EI-MS spectra of the compound showed the molecular ions at m/z 205, based on the mass spectra the molecular formula of compound was established as C16H18O5. The compound exhibits UV absorption at 232nm, 265
nm and 310nm at pH 3.8. However at pH 9.0, while the the 265nm peak and 310nm peak showed a bathochromic shift to 286nm and 355nm respectively (Figure 1 ). This indicates that there are ionizable phenolic groups on aromatic rings. The broad IR absorption at 3437cm-1 indicates -OH stretching frequencies. The peak at 2995 cm-1, 2912cm-1 indicate aromatic C-H stretching. A broad ketonic absorption band at 1660cm-1 indicate probably hydrogen bonded keto group. The structure was further confirmed by 2DHMQCT and GC-EIMS. The corresponding nuclear magnetic resonence signals are; 1H Figure 2 and chemically 
